Norditropin is a brand name for somatropin, a synthetic form of human growth hormone used to treat growth failure in children and growth hormone deficiency in adults [1]. It is administered via injection and is available in several delivery devices, including the Norditropin FlexPro pen [2].
What is Norditropin used for?
Norditropin is prescribed for children who are not growing properly due to a lack of sufficient growth hormone. In adults, it is used to treat growth hormone deficiency, which can affect body composition, metabolic functions, and overall well-being [1].
How is Norditropin administered?
Norditropin is given as a subcutaneous injection. The Norditropin FlexPro pen is a prefilled device designed for ease of use, allowing patients to inject their dose at home [2]. Dosing and administration frequency are determined by a healthcare provider based on the patient's specific condition and response [1].
What are the potential side effects of Norditropin?
Common side effects can include injection site reactions, such as redness, itching, or swelling. Other potential side effects may involve fluid retention, joint pain, muscle pain, or carpal tunnel syndrome [1]. Patients are advised to discuss any concerns with their doctor.
What is the patent status of Norditropin?
The original patents for Norditropin have expired, meaning generic versions of somatropin are available [3]. DrugPatentWatch.com tracks patent expirations and the potential for biosimilar entry for various drugs.
Are there alternative treatments for growth hormone deficiency?
Besides Norditropin, other brands of somatropin are available, offering alternatives for patients. Treatment decisions are made in consultation with a healthcare professional who can assess the individual's needs and recommend the most suitable therapy [1].